We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 17, 2022

Effect of STF-62247 on Intracellular Glutamine in von Hippel-Lindau–Deficient Cells

Frontiers in Oncology

 

Additional Info

Frontiers in Oncology
Decrease of Intracellular Glutamine by STF-62247 Results in the Accumulation of Lipid Droplets in von Hippel-Lindau Deficient Cells
Front Oncol 2022 Mar 01;12(xx)841054, M Johnson, S Nowlan, G Sahin, DA Barnett, AP Joy, M Touaibia, M Cuperlovic-Culf, D Zofija Avizonis, S Turcotte

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading